Neurexophilin-1 is a neuronal protein that plays a critical role in the synaptic functions of the nervous system. As a binding partner for neurexins, which are presynaptic cell-adhesion molecules, Neurexophilin-1 is implicated in the fine-tuning of synaptic connectivity and neurotransmitter release. The precise modulation of Neurexophilin-1 expression is essential for maintaining the intricate balance of neuronal signaling. Dysregulation of its expression can lead to disruptions in synaptic transmission and may contribute to the intricate pathophysiology of nervous system disorders. Consequently, understanding the mechanisms that govern the expression of Neurexophilin-1 is of significant interest in the field of neurobiology. This includes exploring various chemical compounds that have the potential to modulate gene expression, either by direct interaction with the DNA elements that control the transcription of the Neurexophilin-1 gene or through indirect pathways that affect the cellular machinery responsible for gene regulation.
Several chemicals have been identified that could influence the expression of Neurexophilin-1. These include compounds that alter the epigenetic landscape, such as DNA methyltransferase inhibitors, which might reduce the methylation levels on the Neurexophilin-1 gene promoter, potentially leading to a decrease in gene expression. Histone deacetylase inhibitors are another class of compounds that could affect the acetylation state of histones associated with the Neurexophilin-1 gene, causing changes in chromatin structure that might decrease the gene's transcription. Additionally, chemicals like disulfiram, which can inhibit proteasomal function, may indirectly lower Neurexophilin-1 levels by stabilizing the proteins that repress its transcription. The potential inhibitors also extend to natural compounds, such as flavonoids and polyphenols, which are known to possess properties that could lead to the hypoacetylation of histones at gene promoters or inhibition of transcriptional activators, resulting in the downregulation of gene expression. While these interactions offer a fascinating glimpse into the possible modulation of Neurexophilin-1 expression, it's important to note that the actual effects of these chemicals would require rigorous scientific validation through experimental research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A might condense the chromatin structure around the Neurexophilin-1 gene locus, potentially resulting in a downregulation of its transcription due to decreased access for transcription machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
The integration of 5-Azacytidine into the Neurexophilin-1 gene's promoter region could lead to DNA demethylation, thereby disrupting the recruitment of methyl-binding domain proteins and subsequent transcriptional repression, ultimately reducing Neurexophilin-1 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
By inhibiting histone deacetylase activity, Valproic Acid could lead to a tighter chromatin state around the Neurexophilin-1 gene, potentially decreasing the gene's transcriptional activity and reducing its expression. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic Acid could interfere with the transcription of the Neurexophilin-1 gene by inhibiting topoisomerase enzymes, potentially leading to a decrease in the unwinding and rewinding of DNA necessary for transcription elongation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to induce hypoacetylation of histones at gene promoters. This action could lead to the repression of the Neurexophilin-1 gene expression by promoting a closed chromatin conformation that is less accessible for transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might decrease Neurexophilin-1 gene expression by downregulating the activity of specific transcription factors or coactivators required for the initiation of its transcription, leading to a decrease in mRNA levels of Neurexophilin-1. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane could lead to the hypermethylation of the Neurexophilin-1 gene promoter, thereby silencing gene expression through the recruitment of repressive transcriptional machinery and subsequent transcriptional shutdown. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid might lead to a decrease in Neurexophilin-1 expression by causing hypoacetylation of histones at the gene's promoter, resulting in a condensed chromatin state that is not permissive for transcription initiation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine could lead to the downregulation of Neurexophilin-1 expression by reducing the methylation levels of its gene promoter, thereby preventing the binding of transcriptional repressors and reducing overall transcriptional activity. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit the proteasomal degradation of proteins involved in the repression of gene transcription. This might result in increased levels of such repressive proteins in the nucleus, which could contribute to a decrease in Neurexophilin-1 gene expression. | ||||||